Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion type Assertion NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_head.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion description "[This review focuses on ALK rearrangements in NSCLC, starting with the discovery of the EML4-ALK fusion oncogene, and culminating in the recent validation of ALK as a therapeutic target in patients with ALK-rearranged NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_provenance.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion evidence source_evidence_literature NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_provenance.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion SIO_000772 21288922 NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_provenance.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion wasDerivedFrom befree-2016 NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_provenance.
- NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_assertion wasGeneratedBy ECO_0000203 NP869729.RAiboyIshS_JCO5yeyLITipqGy7LHKLE_Xhy4Sx5ZzQ4Q130_provenance.